S&P 500   3,269.96 (-1.21%)
DOW   26,501.60 (-0.59%)
QQQ   269.38 (-2.54%)
AAPL   108.86 (-5.60%)
MSFT   202.47 (-1.10%)
FB   263.11 (-6.31%)
GOOGL   1,616.11 (+3.80%)
AMZN   3,036.15 (-5.45%)
TSLA   388.04 (-5.55%)
NVDA   501.36 (-3.76%)
BABA   304.69 (-2.52%)
CGC   18.78 (+0.00%)
GE   7.42 (+0.68%)
MU   50.34 (-0.28%)
AMD   75.29 (-3.50%)
T   27.02 (+0.97%)
F   7.73 (-2.15%)
ACB   4.05 (-0.98%)
GILD   58.15 (-0.65%)
NIO   30.58 (-4.41%)
NFLX   475.74 (-5.65%)
BA   144.39 (-2.63%)
DIS   121.25 (-0.24%)
S&P 500   3,269.96 (-1.21%)
DOW   26,501.60 (-0.59%)
QQQ   269.38 (-2.54%)
AAPL   108.86 (-5.60%)
MSFT   202.47 (-1.10%)
FB   263.11 (-6.31%)
GOOGL   1,616.11 (+3.80%)
AMZN   3,036.15 (-5.45%)
TSLA   388.04 (-5.55%)
NVDA   501.36 (-3.76%)
BABA   304.69 (-2.52%)
CGC   18.78 (+0.00%)
GE   7.42 (+0.68%)
MU   50.34 (-0.28%)
AMD   75.29 (-3.50%)
T   27.02 (+0.97%)
F   7.73 (-2.15%)
ACB   4.05 (-0.98%)
GILD   58.15 (-0.65%)
NIO   30.58 (-4.41%)
NFLX   475.74 (-5.65%)
BA   144.39 (-2.63%)
DIS   121.25 (-0.24%)
S&P 500   3,269.96 (-1.21%)
DOW   26,501.60 (-0.59%)
QQQ   269.38 (-2.54%)
AAPL   108.86 (-5.60%)
MSFT   202.47 (-1.10%)
FB   263.11 (-6.31%)
GOOGL   1,616.11 (+3.80%)
AMZN   3,036.15 (-5.45%)
TSLA   388.04 (-5.55%)
NVDA   501.36 (-3.76%)
BABA   304.69 (-2.52%)
CGC   18.78 (+0.00%)
GE   7.42 (+0.68%)
MU   50.34 (-0.28%)
AMD   75.29 (-3.50%)
T   27.02 (+0.97%)
F   7.73 (-2.15%)
ACB   4.05 (-0.98%)
GILD   58.15 (-0.65%)
NIO   30.58 (-4.41%)
NFLX   475.74 (-5.65%)
BA   144.39 (-2.63%)
DIS   121.25 (-0.24%)
S&P 500   3,269.96 (-1.21%)
DOW   26,501.60 (-0.59%)
QQQ   269.38 (-2.54%)
AAPL   108.86 (-5.60%)
MSFT   202.47 (-1.10%)
FB   263.11 (-6.31%)
GOOGL   1,616.11 (+3.80%)
AMZN   3,036.15 (-5.45%)
TSLA   388.04 (-5.55%)
NVDA   501.36 (-3.76%)
BABA   304.69 (-2.52%)
CGC   18.78 (+0.00%)
GE   7.42 (+0.68%)
MU   50.34 (-0.28%)
AMD   75.29 (-3.50%)
T   27.02 (+0.97%)
F   7.73 (-2.15%)
ACB   4.05 (-0.98%)
GILD   58.15 (-0.65%)
NIO   30.58 (-4.41%)
NFLX   475.74 (-5.65%)
BA   144.39 (-2.63%)
DIS   121.25 (-0.24%)
Log in
NYSE:CLB

Core Laboratories Stock Forecast, Price & News

$14.45
+0.23 (+1.62 %)
(As of 10/30/2020 12:00 AM ET)
Add
Compare
Today's Range
$14.01
Now: $14.45▼
$14.64
50-Day Range
$14.03
MA: $16.03▼
$19.00
52-Week Range
$6.68
Now: $14.45▼
$49.22
Volume433,879 shs
Average Volume1.11 million shs
Market Capitalization$642.95 million
P/E RatioN/A
Dividend Yield0.28%
Beta3.15
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and petroleum products; and proprietary and joint industry studies. The Production Enhancement segment comprises services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories N.V. was founded in 1936 and is based in Amsterdam, the Netherlands.
Read More
Core Laboratories logo

Beat the Market (BTM) Rank™

Analyst Opinion: 3.1Community Rank: 2.1Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

1.69 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Oil & gas field services, not elsewhere classified
Sub-IndustryN/A
SectorOils/Energy
Current SymbolNYSE:CLB
Previous Symbol
CUSIPN/A
CIK1000229
Webwww.corelab.com
Phone31-20-420-3191
Employees4,300

Debt

Debt-to-Equity Ratio2.64
Current Ratio0.99
Quick Ratio0.74

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E Ratio18.77
P/E Growth4.13

Sales & Book Value

Annual Sales$668.21 million
Price / Sales0.96
Cash Flow$2.17 per share
Price / Cash Flow6.65
Book Value$4.10 per share
Price / Book3.52

Profitability

EPS (Most Recent Fiscal Year)$1.79
Net Income$101.98 million
Net Margins-19.02%
Return on Equity45.39%
Return on Assets6.74%

Miscellaneous

Outstanding Shares44,495,000
Market Cap$642.95 million
Next Earnings Date2/3/2021 (Estimated)
OptionableOptionable
$14.45
+0.23 (+1.62 %)
(As of 10/30/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CLB News and Ratings via Email

Sign-up to receive the latest news and ratings for CLB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Core Laboratories (NYSE:CLB) Frequently Asked Questions

How has Core Laboratories' stock been impacted by Coronavirus (COVID-19)?

Core Laboratories' stock was trading at $10.93 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CLB stock has increased by 32.2% and is now trading at $14.45.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of Core Laboratories?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 12 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Core Laboratories.

When is Core Laboratories' next earnings date?

Core Laboratories is scheduled to release its next quarterly earnings announcement on Wednesday, February 3rd 2021.
View our earnings forecast for Core Laboratories.

How were Core Laboratories' earnings last quarter?

Core Laboratories (NYSE:CLB) released its quarterly earnings results on Wednesday, October, 21st. The oil and gas company reported $0.16 earnings per share for the quarter, beating analysts' consensus estimates of $0.14 by $0.02. The oil and gas company earned $105.38 million during the quarter, compared to analyst estimates of $109.33 million. Core Laboratories had a negative net margin of 19.02% and a positive return on equity of 45.39%. The business's revenue was down 39.2% compared to the same quarter last year. During the same period in the prior year, the company posted $0.50 EPS.
View Core Laboratories' earnings history.

How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories?

Core Laboratories announced a quarterly dividend on Thursday, October 15th. Investors of record on Monday, October 26th will be given a dividend of $0.01 per share on Tuesday, November 17th. This represents a $0.04 annualized dividend and a yield of 0.28%. The ex-dividend date of this dividend is Friday, October 23rd.
View Core Laboratories' dividend history.

What price target have analysts set for CLB?

14 brokerages have issued twelve-month price objectives for Core Laboratories' shares. Their forecasts range from $11.00 to $38.80. On average, they expect Core Laboratories' share price to reach $23.86 in the next twelve months. This suggests a possible upside of 65.1% from the stock's current price.
View analysts' price targets for Core Laboratories.

Who are some of Core Laboratories' key competitors?

Some companies that are related to Core Laboratories include Subsea 7 (SUBCY), Liberty Oilfield Services (LBRT), National Energy Services Reunited (NESR), RPC (RES), Oceaneering International (OII), NexTier Oilfield Solutions (NEX), ProPetro (PUMP), Franks International (FI), Helix Energy Solutions Group (HLX), Select Energy Services (WTTR), North American Construction Group (NOA), Keane Group (FRAC), Natural Gas Services Group (NGS), Superior Energy Services (SPNVD) and Mammoth Energy Services (TUSK).
View all competitors.

What other stocks do shareholders of Core Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), BlackRock (BLK), Starbucks (SBUX), Micron Technology (MU), Chipotle Mexican Grill (CMG), Endologix (ELGX), Intel (INTC), Netflix (NFLX), AT&T (T) and Gilead Sciences (GILD).

Who are Core Laboratories' key executives?

Core Laboratories' management team includes the following people:
  • Mr. Lawrence V. Bruno, Chairman, CEO, Pres & COO (Age 60, Pay $1.28M)
  • Mr. Christopher Scott Hill, Sr. VP & CFO (Age 50, Pay $448.02k)
  • Mr. David M. Demshur, Exec. Officer (Age 65, Pay $2.36M)
  • Mr. Kevin G. Daniels, Chief Accounting Officer, Treasurer & VP (Age 56)
  • Ms. Gwendolyn Y. Schreffler M.B.A., Sr. VP of Corp. Devel. & Investor Relations

What is Core Laboratories' stock symbol?

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

Who are Core Laboratories' major shareholders?

Core Laboratories' stock is owned by a number of institutional and retail investors. Top institutional investors include Douglas Lane & Associates LLC (1.19%), WINTON GROUP Ltd (0.25%), Scout Investments Inc. (0.15%), Envestnet Asset Management Inc. (0.08%), Louisiana State Employees Retirement System (0.05%) and BNP Paribas Arbitrage SA (0.03%). Company insiders that own Core Laboratories stock include Gregory Barry Barnett, Jan Willem Sodderland, Kevin Daniels, Lawrence Bruno and Mark F Elvig.
View institutional ownership trends for Core Laboratories.

Which major investors are selling Core Laboratories stock?

CLB stock was sold by a variety of institutional investors in the last quarter, including WINTON GROUP Ltd, BNP Paribas Arbitrage SA, Scout Investments Inc., and OLD National Bancorp IN.
View insider buying and selling activity for Core Laboratories.

Which major investors are buying Core Laboratories stock?

CLB stock was purchased by a variety of institutional investors in the last quarter, including Douglas Lane & Associates LLC, Campbell & CO Investment Adviser LLC, Louisiana State Employees Retirement System, New Mexico Educational Retirement Board, New Mexico Educational Retirement Board, Envestnet Asset Management Inc., Cerebellum GP LLC, and First Bank & Trust. Company insiders that have bought Core Laboratories stock in the last two years include Gregory Barry Barnett, Jan Willem Sodderland, and Lawrence Bruno.
View insider buying and selling activity for Core Laboratories.

How do I buy shares of Core Laboratories?

Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Core Laboratories' stock price today?

One share of CLB stock can currently be purchased for approximately $14.45.

How big of a company is Core Laboratories?

Core Laboratories has a market capitalization of $642.95 million and generates $668.21 million in revenue each year. The oil and gas company earns $101.98 million in net income (profit) each year or $1.79 on an earnings per share basis. Core Laboratories employs 4,300 workers across the globe.

What is Core Laboratories' official website?

The official website for Core Laboratories is www.corelab.com.

How can I contact Core Laboratories?

Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The oil and gas company can be reached via phone at 31-20-420-3191 or via email at [email protected]

This page was last updated on 10/30/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.